Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance with Targeted Agents

The Present and Future of HER2-Targeted Therapy in Colorectal and Other GI Cancers

Friday, July 1, 2022

14:25 – 14:55

Location: Rooms 111-112; Level 1

Session Speaker(s)

Supported by Daiichi